Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia) — NOC01  

Nocturia Due to Nocturnal Polyuria Clinical Trial

Official title: Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet 25μg / 50μg in Treatment for Male Nocturia Due to Nocturnal Polyuria

Status Completed

Clinical Trial Summary

To investigate the incidence and risk factors of desmopressin-induced hyponatremia during long-term treatment (1 year [52 weeks]) of MINIRINMELT orally disintegrating (OD) tablets 25μg/50μg (drug) for nocturia caused by nocturnal polyuria in men in daily clinical practice, and to confirm the compliance with proper use of this drug in clinical practice and to investigate the effectiveness of risk minimization activities.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Nocturia
• Nocturia Due to Nocturnal Polyuria
• Polyuria

• NCT number: NCT04329975
• Study type: Observational [Patient Registry]
• Source: Ferring Pharmaceuticals
• Status: Completed
• Start date: May 19, 2020
• Completion date: September 30, 2023